Author: OurCrowd

[Trendlines in The Times of Israel] Trendlines gets grant for urinary incontinence device

Trendlines Labs is to receive a grant from the Singapore Israel Industrial Research and Development Foundation for the development and clinical trial of its stress urinary incontinence (SUI) product, which is being developed in partnership with the Singapore General Hospital. The 50 women in the trial, expected to start mid-2017 at the hospital, will provide feedback on the product. The foundation will provide up to 50 percent of the $400,000 the partners need to fund the final product development and clinical trial. Read more on The Times of Israel...

Read More

[BioCatch in Security News Desk] Getting personal with biometrics for security

Another pertinent example of banks gravitating towards biometrics is, undoubtedly, the successful trial conducted by BioCatch – which specialises in behavioural biometrics – at NatWest Bank. The bank has been deploying the BioCatch technology since the start of 2016 within Coutts and for some of its business customers. Simon McNamara, Chief Administrative Officer at NatWest has been impressed with the breadth of behavioural biometrics that the BioCatch technology can monitor: “We’ve already seen many examples of it alerting us to suspicious activity and protecting our customers from fraud,” he says. Read more on Security News Desk...

Read More

[Pixie in VentureBeat] Pixie Technology uses fobs and augmented reality to locate your lost wallet

Pixie Technology has a way to find your lost wallet or misplaced keys. It uses a combination of tracking chips, which the company dubbed the “location of things,” along with augmented reality technology. Los Altos, Calif.-based Pixie sells Bluetooth LE-connected fobs that create a connection with each other. When you are holding a fob, such as the one attached to your smartphone, it establishes a connection to the nearby fob. And then it uses the location information to guide you to the other fob. Read more on VentureBeat...

Read More